Infectious Disease · PANCE / PANRE

Chlamydia trachomatis Genital Infection

Most common bacterial STI in the US — often asymptomatic; serotypes D-K cause urogenital infection. Cervicitis/urethritis treated with doxycycline.

Also known as: chlamydia, Chlamydia trachomatis, urethritis, cervicitis, PID

Overview

Infection of genitourinary epithelium by Chlamydia trachomatis, an obligate intracellular gram-negative bacterium. Serovars D-K cause urogenital infection; A-C cause trachoma (ocular); L1-L3 cause lymphogranuloma venereum. Vertical transmission causes neonatal conjunctivitis and pneumonia.

Epidemiology

Most commonly reported notifiable infection in the US — 1.6 million cases in 2022 (CDC), with true incidence likely much higher due to asymptomatic infection. Peaks in ages 15-24; women disproportionately affected. Frequently coinfects with gonorrhea.

Try two board-style Chlamydia trachomatis Genital Infection questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1ReproductiveMedium
A 22-year-old woman presents with 5 days of yellow vaginal discharge and mild dysuria. She has a new sexual partner and inconsistent condom use. She denies abdominal pain, fever, or abnormal bleeding. Temperature 37.0 C, BP 118/74 mm Hg. Pelvic exam shows mucopurulent cervical discharge without cervical motion tenderness. Nucleic acid amplification testing of a vaginal swab is positive for Chlamydia trachomatis and negative for Neisseria gonorrhoeae. Urine pregnancy test is negative. Which of the following is the recommended first-line treatment?
  • AMetronidazole 500 mg orally twice daily for 7 days
  • BDoxycycline 100 mg orally twice daily for 7 days
  • CCeftriaxone 500 mg intramuscularly once
  • DAmoxicillin 500 mg orally 3 times daily for 7 days
  • EAzithromycin 1 g orally once
Reveal answer & full explanation
Correct answer: B — Doxycycline 100 mg orally twice daily for 7 days
  • AMetronidazole 500 mg orally twice daily for 7 days
  • BDoxycycline 100 mg orally twice daily for 7 days✓
  • CCeftriaxone 500 mg intramuscularly once
  • DAmoxicillin 500 mg orally 3 times daily for 7 days
  • EAzithromycin 1 g orally once

Why Doxycycline 100 mg orally twice daily for 7 days is correct

  • Doxycycline 100 mg orally twice daily for 7 days is the current CDC first-line treatment for uncomplicated urogenital Chlamydia trachomatis infection in nonpregnant adults (2021 STI Treatment Guidelines)
  • Microbiologic cure rates with doxycycline are superior to single-dose azithromycin (approximately 97% vs 94%)
  • Azithromycin failures are substantially higher for rectal chlamydia specifically

Why the others are wrong

  • Azithromycin 1 g orally once — previously co-first-line and still acceptable when adherence is a concern or in pregnancy, but no longer the preferred regimen because of inferior efficacy
  • Ceftriaxone 500 mg intramuscularly once — first-line for gonorrhea, not chlamydia; would be added if NAAT were positive for N. gonorrhoeae or empirically when gonorrhea cannot be excluded
  • Metronidazole 500 mg orally twice daily for 7 days — covers trichomoniasis and bacterial vaginosis, not chlamydia
  • Amoxicillin 500 mg orally 3 times daily for 7 days — an alternative regimen for chlamydia in pregnancy, which tempts students treating a woman of reproductive age, but her pregnancy test is negative and amoxicillin is not a recommended regimen for nonpregnant adults, in whom doxycycline is preferred

Additional high-yield points

  • Sexual partners within the past 60 days should be evaluated and treated
  • The patient should abstain from intercourse for 7 days after starting therapy
  • Test of reinfection (not test of cure) is recommended at 3 months
Question 2Infectious DiseaseMedium
A 32-year-old man develops fever, night sweats, and tender bilateral inguinal lymphadenopathy three weeks after unprotected intercourse. He recalls a small, painless penile ulcer that has since healed. Nucleic acid amplification testing of an inguinal lymph node aspirate is positive for Chlamydia trachomatis. Which of the following is the most likely diagnosis?
  • ALymphogranuloma venereum
  • BGranuloma inguinale
  • CChancroid
  • DPrimary syphilis
  • EPrimary genital herpes
Reveal answer & full explanation
Correct answer: A — Lymphogranuloma venereum
  • ALymphogranuloma venereum✓
  • BGranuloma inguinale
  • CChancroid
  • DPrimary syphilis
  • EPrimary genital herpes

Why Lymphogranuloma venereum is correct

  • Caused by the invasive Chlamydia trachomatis serovars L1-L3; a positive C. trachomatis NAAT from a lymph node aspirate plus a compatible syndrome is enough to diagnose and treat, because serovar genotyping is not widely available
  • Classic course: a small painless primary ulcer (often already healed) followed by painful, tender inguinal lymphadenopathy (buboes)
  • The 'groove sign' occurs when adenopathy forms both above and below the inguinal ligament

Why the others are wrong

  • Chancroid — Haemophilus ducreyi causes a painful (not painless) genital ulcer with tender adenopathy, but the node aspirate would not be positive for C. trachomatis (premature closure on 'painful ulcer with nodes')
  • Granuloma inguinale — Klebsiella granulomatis causes progressive beefy-red ulcerative lesions without true buboes (buzzword-matching on tropical STI)
  • Primary syphilis — Treponema pallidum produces a painless chancre with nontender, rubbery regional nodes rather than tender buboes, and would not yield a C. trachomatis-positive node aspirate (anchoring on 'painless ulcer = syphilis')
  • Primary genital herpes — primary herpes simplex infection does cause fever, malaise, and tender bilateral inguinal lymphadenopathy, but its lesions are multiple painful vesicles that erode into shallow ulcers, the adenopathy accompanies the active lesions rather than following a healed painless ulcer by weeks, and the node aspirate would not be positive for C. trachomatis (anchoring on 'fever with tender bilateral nodes')

Additional high-yield points

  • Rectal LGV (common in men who have sex with men): proctitis, rectal pain, bloody discharge
  • Treatment: doxycycline 100 mg twice daily for 21 days; test and treat partners
  • Fluctuant buboes may be aspirated through intact skin or incised and drained to prevent inguinal or femoral ulceration (CDC 2021)

That's 2. Get 7,700+ more.

Unlock the full FirstPassPA bank: 7,700+ board-style questions, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.

Start your 7-day free trial →
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Chlamydia trachomatis Genital Infection outline — plus all 514 diagnoses, 7,700+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Age <25, multiple sexual partners
  • New partner within 60 days, inconsistent condom use
  • Prior STI history
  • Sex work, MSM (rectal/pharyngeal infection)
  • Mother with untreated chlamydia (neonatal infection)

Pathophysiology

Elementary bodies (infectious form) attach to and invade columnar epithelial cells of cervix, urethra, rectum, conjunctiva. Inside, they convert to reticulate bodies and replicate within inclusions, then revert to elementary bodies and are released. Persistent infection drives chronic inflammation that scars the upper genital tract — causing tubal infertility and chronic pelvic pain.

Clinical presentation

Symptoms

  • Women (often asymptomatic): mucopurulent cervical discharge, intermenstrual or post-coital bleeding, dysuria
  • Men: urethral discharge (clearer/whiter than gonorrhea), dysuria, urethral itching; ~50% asymptomatic
  • Rectal infection: often asymptomatic; proctitis with pain, discharge, tenesmus possible
  • Pharyngeal: usually asymptomatic
  • Neonatal: conjunctivitis (5-14 days), staccato-cough pneumonia (3-12 weeks)
  • Reiter syndrome (reactive arthritis): urethritis + conjunctivitis + asymmetric oligoarthritis

Signs / physical exam

  • Mucopurulent cervical discharge; friable cervix; cervical motion tenderness
  • Urethral meatus erythema, discharge expressible
  • Lower abdominal tenderness if ascending infection
  • Conjunctival injection with mucopurulent discharge (neonate or adult inclusion conjunctivitis)

Classic findings

Sexually active young woman with intermenstrual or post-coital bleeding and mucopurulent cervicitis — chlamydia until proven otherwise. Test all sexually active women under 25 annually.

Differential diagnosis

  • Gonorrhea — More purulent discharge, concurrent in ~30%; treat for both empirically
  • Mycoplasma genitalium — Persistent urethritis/cervicitis after standard therapy; NAAT; macrolide resistance common
  • Trichomoniasis — Frothy, malodorous vaginal discharge, strawberry cervix; NAAT or wet mount
  • Bacterial vaginosis — Thin gray discharge, fishy odor, clue cells, pH >4.5
  • HSV cervicitis — Painful vesicles/ulcers, dysuria; PCR
  • Pelvic inflammatory disease — Adnexal/cervical motion tenderness, fever; treat broadly
  • UTI — Abrupt dysuria and frequency, often hematuria; nitrite or urine culture positive. Dysuria with pyuria but a sterile culture (sterile pyuria) in a young sexually active woman suggests chlamydial or gonococcal urethritis, so send NAAT

Diagnostic workup

Diagnostic criteria

Positive NAAT in symptomatic or screened asymptomatic patient.

Labs

  • Nucleic acid amplification test (NAAT) — gold standard; sensitivity >95%
  • Specimens: first-catch urine (men/women), endocervical swab, vaginal swab (provider or patient self-collected), urethral swab, rectal swab, pharyngeal swab
  • Co-test for gonorrhea at the same time and site (frequent coinfection)
  • Screen for syphilis and HIV; offer hepatitis screening as indicated
  • Wet mount for trichomoniasis if discharge
  • USPSTF recommends annual chlamydia screening for sexually active women <25 and older women with risk factors

Imaging

  • Pelvic ultrasound if PID with tubo-ovarian abscess suspected
  • Generally none required for uncomplicated infection

Diagnostic algorithm

Population/SiteFirst-line TherapyNotes
Urogenital (non-pregnant)Doxycycline 100 mg BID x 7 dPreferred over azithromycin
PregnancyAzithromycin 1 g PO x 1Doxycycline contraindicated; test of cure at 4 wk
RectalDoxycycline 100 mg BID x 7 dAzithromycin inferior here
LGV (L1-L3)Doxycycline 100 mg BID x 21 dInguinal/anal bubo; MSM
NeonatalErythromycin x 14 d (PO)Counsel for pyloric stenosis risk
CDC 2021 chlamydia treatment by site and host.

Treatment

First-line

  • Uncomplicated urogenital chlamydia (CDC 2021):
  • • Doxycycline 100 mg PO BID × 7 days — preferred (more effective than azithromycin for rectal and pharyngeal infections)
  • • Azithromycin 1 g PO × 1 — alternative if adherence concerns or pregnancy (single dose, observed therapy)
  • Rectal chlamydia: doxycycline 100 mg PO BID × 7 days (azithromycin inferior)
  • LGV (L1-L3 serovars): doxycycline 100 mg PO BID × 21 days
  • Pregnancy: azithromycin 1 g PO × 1 (doxycycline contraindicated)
  • Neonatal conjunctivitis or pneumonia: erythromycin base or ethylsuccinate PO × 14 days (parents counseled about pyloric stenosis risk)
  • Ceftriaxone for gonorrhea + doxycycline for chlamydia — treat both presumptively for cervicitis in women at increased risk (age <25, new partner, partner with an STI) or when follow-up is uncertain or NAAT is unavailable, and for urethritis when a point-of-care Gram stain is unavailable; if the chlamydia NAAT is positive and the gonorrhea NAAT negative, doxycycline alone is enough; PID adds metronidazole and extends therapy to 14 days

Second-line / adjunct

  • Levofloxacin 500 mg PO daily × 7 days — alternative regimen (as is azithromycin 1 g PO × 1)
  • Expedited partner therapy (EPT) — provide medication or prescription to give to partners (legal in most states)
  • Test of cure NOT routinely recommended (except pregnancy at 4 weeks post-treatment)
  • Rescreen at 3 months for reinfection regardless of partner treatment

Complications

  • Pelvic inflammatory disease (PID) → tubal infertility, ectopic pregnancy, chronic pelvic pain
  • Fitz-Hugh-Curtis syndrome (perihepatitis with 'violin string' adhesions and RUQ pain)
  • Epididymitis, prostatitis (men)
  • Reactive arthritis (Reiter syndrome)
  • Neonatal conjunctivitis (1-2 weeks), pneumonia (3-12 weeks)
  • Increased HIV transmission risk

PANCE pearls

  • Doxycycline is now preferred over single-dose azithromycin for urogenital chlamydia (CDC 2021) — particularly important for rectal infections.
  • Routine annual NAAT screening for all sexually active women <25 (USPSTF Grade B).
  • Treat partners and counsel for 7 days of abstinence after treatment to prevent reinfection.
  • Persistent symptoms after appropriate therapy — consider Mycoplasma genitalium (NAAT) or reinfection.
  • Pregnancy: azithromycin replaces doxycycline; test of cure at 4 weeks post-treatment.

References

  • CDC 2021 — Sexually Transmitted Infections Treatment Guidelines, 2021 (MMWR Recommendations and Reports)
  • USPSTF 2021 — Screening for Chlamydia and Gonorrhea: US Preventive Services Task Force Recommendation Statement
  • CDC Surveillance — Sexually Transmitted Disease Surveillance — Chlamydia chapter

Practice Infectious Disease questions on FirstPassPA

Turn this outline into retention. 7,700+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start your 7-day free trial → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.